pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Small Molecules
drug
save

Small Molecules

Preclinicalupdated 3mo ago
by Vincere Biosciences Inc
Preclinical
community read0 votes

🐶 often sniffed alongside

top 2
  • tagDermatology1 co-mentions · 1 sources
  • tagMicrobiome1 co-mentions · 1 sources

indications

indications
Parkinson's Disease

all catalysts(0)

nothing on the calendar yet

News(10)

  • STAT+: One of the most consequential years for cancer treatment, ever
    Between success with a pancreatic cancer drug and now success with an mRNA neoantigen vaccine, it has been a banner year for developing cancer therapies.
    stat · 20h ago
  • Kolon TissueGene cuts 37 US staffers after Phase 3 fail
    Follow along as BioSpace tracks job cuts and restructuring initiatives.
    biospace · 1d ago
  • BioMarin bulks up bone unit with $275M Alesta buyout to challenge AstraZeneca
    BioMarin Pharmaceutical has agreed to buy Alesta Therapeutics for $275 million upfront, positioning the biopharma to challenge AstraZeneca in the rare bone disease market.
    fiercebiotech · 2d ago
  • Capricor soars on potential FDA review extension, filing amendments
    Capricor Therapeutics’ CEO Linda Marbán believes the FDA is willing to work with the biotech as the Aug. 22 deadline approaches for its Duchenne muscular dystrophy cell therapy deramiocel, with the…
    biospace · 6d ago
  • ‘We’re not afraid of competition’: BioCryst CEO sets out strategy after scrapping internal discovery
    BioCryst CEO Charlie Gayer told Fierce the company is “not getting away from science and R&D” despite shutting down its internal discovery efforts.
    fiercebiotech · 6d ago
  • Chutes & Ladders—Former Legend CEO lands at K2
    Just weeks after Legend Biotech announced the departure of its CEO, Ying Huang, K2 Therapeutics has announced that Wang will now lead the startup, which was founded in 2024 with a $50 million seed…
    fiercebiotech · 7d ago
  • Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill
    Three years after Robert Hoffman sold XinThera to Gilead, the veteran Pfizer chemist has unveiled his latest venture.
    fiercebiotech · 8d ago
  • With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug development
    AI is quickly becoming a central force in drug development, from powering pharma engines to permanently rewiring the capital markets.
    biospace · 9d ago
  • Building Resilience for the Future of Biopharma Innovation
    How can industry build resilience as science advances? WuXi AppTec Co-CEO Dr. Steve Yang shares his perspective on the future of biopharma innovation.
    fiercebiotech · 9d ago
  • BMS picks Texas for new $2.3B manufacturing campus
    Bristol Myers Squibb’s $2.3 billion Houston manufacturing campus is part of the company’s larger $40 billion investment designed to bolster American innovation and manufacturing.
    biospace · 10d ago
view all news mentions →
indication
Parkinson's Disease
phase
preclinical
Data sources
ClinicalTrials.gov
last refreshed 8m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?